4.7 Article

Design and synthesis of new non nucleoside inhibitors of DNMT3A

Journal

BIOORGANIC & MEDICINAL CHEMISTRY
Volume 23, Issue 17, Pages 5946-5953

Publisher

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmc.2015.06.066

Keywords

DNA methylation; DNMT3A; Reactive inhibitor; Michael acceptor

Funding

  1. Centre National de la Recherche Scientifique (CNRS, France)
  2. Region Midi Pyrenees France [Equipe d'Excellence]
  3. Region Midi Pyrenees France [FEDER CNRS/Region Midi Pyrenees]
  4. Fondation pour la Recherche Medicale [FDT20140930846]

Ask authors/readers for more resources

DNA methylation, an epigenetic modification regulating gene expression, is a promising target in cancer. In an effort to identify new non nucleosidic inhibitors of DNA methyltransferases, the enzymes responsible for DNA methylation, we carried out a high-throughput screening of 66,000 chemical compounds based on an enzymatic assay against catalytic DNMT3A. A family of propiophenone derivatives was identified. After chemical optimization and structure activity relationship studies, a new inhibitor ( 33) was obtained with an EC50 of 2.1 mu M against DNMT3A. The mechanism of inhibition of the compound was investigated as it forms a reactive Michael acceptor group in situ. Thereby, the Michael acceptor 20 was identified. This compound was further characterized for its biological activity in cancer cells. (C) 2015 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available